Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Unusual pulmonary toxicity of ipilimumab treated by macrolides.

Mailleux M, Cornélis F, Colin GC, Baurain JF.

Acta Clin Belg. 2015 Dec;70(6):442-4. doi: 10.1080/17843286.2015.1107200.

PMID:
26790556
2.

Melanoma burden by melanoma stage: Assessment through a disease transition model.

Tromme I, Legrand C, Devleesschauwer B, Leiter U, Suciu S, Eggermont A, Francart J, Calay F, Haagsma JA, Baurain JF, Thomas L, Beutels P, Speybroeck N.

Eur J Cancer. 2016 Jan;53:33-41. doi: 10.1016/j.ejca.2015.09.016. Epub 2015 Dec 13.

PMID:
26693897
3.

Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma.

Decoster L, Vande Broek I, Neyns B, Majois F, Baurain JF, Rottey S, Rorive A, Anckaert E, De Mey J, De Brakeleer S, De Grève J.

Anticancer Res. 2015 Dec;35(12):6893-9.

PMID:
26637913
4.

Unusual pulmonary toxicity of ipilimumab treated by macrolides.

Mailleux M, Cornélis F, Colin G, Baurain JF.

Acta Clin Belg. 2015 Jul 13:2295333715Y0000000047. [Epub ahead of print]

PMID:
26166488
5.

Pembrolizumab versus Ipilimumab in Advanced Melanoma.

Robert C, Schachter J, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, Larkin J, Lorigan P, Neyns B, Blank CU, Hamid O, Mateus C, Shapira-Frommer R, Kosh M, Zhou H, Ibrahim N, Ebbinghaus S, Ribas A; KEYNOTE-006 investigators.

N Engl J Med. 2015 Jun 25;372(26):2521-32. doi: 10.1056/NEJMoa1503093. Epub 2015 Apr 19.

6.

Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma.

Duerinck J, Clement PM, Bouttens F, Andre C, Neyns B, Staelens Y, Van Fraeyenhove F, Baurain JF, Luce S, D'hondt L, Joosens E, Specenier P, Verschaeve V, Filleul B, Vroman P, Stragier B, Rogiers A.

J Neurol. 2015 Mar;262(3):742-51. doi: 10.1007/s00415-014-7633-z. Epub 2015 Jan 9.

PMID:
25572162
7.

Radical resection of noncolorectal liver metastases: is cure possible?

Ghammad K, Heuker D, Stainier L, Hubert C, Humblet Y, Baurain JF, Lannoy, Gigot J.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1374-9. No abstract available.

PMID:
25513099
8.

Radical resection of noncolorectal liver metastases: is cure possible?

Ghammad K, Heuker D, Stainier L, Hubert C, Humblet Y, Baurain JF, Lannoy, Gigot J.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1374-9. No abstract available.

PMID:
25436314
9.

Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical nevi.

Tromme I, Devleesschauwer B, Beutels P, Richez P, Praet N, Sacré L, Marot L, Van Eeckhout P, Theate I, Baurain JF, Lambert J, Legrand C, Thomas L, Speybroeck N.

PLoS One. 2014 Oct 14;9(10):e109339. doi: 10.1371/journal.pone.0109339. eCollection 2014.

10.

Health-related quality of life in patients with melanoma expressed as utilities and disability weights.

Tromme I, Devleesschauwer B, Beutels P, Richez P, Leroy A, Baurain JF, Cornelis F, Bertrand C, Legrand N, Degueldre J, Thomas L, Legrand C, Lambert J, Haagsma J, Speybroeck N.

Br J Dermatol. 2014 Dec;171(6):1443-50. doi: 10.1111/bjd.13262. Epub 2014 Nov 19.

PMID:
25039853
11.

A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery.

Vergote I, Oaknin A, Baurain JF, Ananda S, Wong S, Su X, Wu B, Zhong Z, Warner D, Casado A.

Eur J Cancer. 2014 Sep;50(14):2408-16. doi: 10.1016/j.ejca.2014.06.010. Epub 2014 Jul 15.

PMID:
25037684
12.

Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer.

Luyckx M, Votino R, Squifflet JL, Baurain JF.

Int J Womens Health. 2014 Mar 31;6:351-8. doi: 10.2147/IJWH.S39696. eCollection 2014. Review.

13.

Local immunostimulation leading to rejection of accepted male skin grafts by female mice as a model for cancer immunotherapy.

Bourdeaux C, Lurquin C, Jacquemart I, Lethé B, Brasseur F, van Baren N, Baurain JF, Dyson J, Van Snick J, Uyttenhove C, Boon T.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3502-7. doi: 10.1073/pnas.1401115111. Epub 2014 Feb 18.

14.

A short treatment with galactomannan GM-CT-01 corrects the functions of freshly isolated human tumor-infiltrating lymphocytes.

Demotte N, Bigirimana R, Wieërs G, Stroobant V, Squifflet JL, Carrasco J, Thielemans K, Baurain JF, Van Der Smissen P, Courtoy PJ, van der Bruggen P.

Clin Cancer Res. 2014 Apr 1;20(7):1823-33. doi: 10.1158/1078-0432.CCR-13-2459. Epub 2014 Feb 13.

15.

Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.

Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, Marshall E, Scheulen M, Jouary T, Negrier S, Vermorken JB, Kaempgen E, Durando X, Schadendorf D, Gurunath RK, Keilholz U.

Ann Oncol. 2014 Mar;25(3):742-6. doi: 10.1093/annonc/mdt585. Epub 2014 Feb 7.

16.

A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.

Campone M, Berton-Rigaud D, Joly-Lobbedez F, Baurain JF, Rolland F, Stenzl A, Fabbro M, van Dijk M, Pinkert J, Schmelter T, de Bont N, Pautier P.

Oncologist. 2013;18(11):1190-1. doi: 10.1634/theoncologist.2013-0061. Epub 2013 Oct 8.

17.

Tamoxifen and ovarian function.

Berliere M, Duhoux FP, Dalenc F, Baurain JF, Dellevigne L, Galant C, Van Maanen A, Piette P, Machiels JP.

PLoS One. 2013 Jun 28;8(6):e66616. doi: 10.1371/journal.pone.0066616. Print 2013.

18.

Tracking of second primary melanomas in vemurafenib-treated patients.

Dalle S, Poulalhon N, Debarbieux S, Zaharia D, Mihm MC, Lacouture ME, Rosen A, Marghoob AA, Busam KJ, Depaepe L, Bringuier PP, Richez P, Baurain JF, Bressac-de Paillerets B, Balme B, Thomas L.

JAMA Dermatol. 2013 Apr;149(4):488-90. doi: 10.1001/jamadermatol.2013.21. No abstract available.

PMID:
23715012
19.

Lymphoid neogenesis in melanoma: What does it tell us?

van Baren N, Baurain JF, Coulie PG.

Oncoimmunology. 2013 Jan 1;2(1):e22505.

20.

Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases.

Cipponi A, Mercier M, Seremet T, Baurain JF, Théate I, van den Oord J, Stas M, Boon T, Coulie PG, van Baren N.

Cancer Res. 2012 Aug 15;72(16):3997-4007. Epub 2012 Jul 31.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk